Axa
DCPH

Axa’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Axa’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6,400
Closed -$287K – 1317
2021
Q1 		$287K Sell
6,400
-51,479
-89% -$2.4M ﹤0.01% 1149
2020
Q4 		$3.3M Buy
57,879
+2,072
+4% +$123K 0.01% 776
2020
Q3 		$2.86M Sell
55,807
-7,295
-12% -$357K 0.01% 751
2020
Q2 		$3.77M Sell
63,102
-5,169
-8% -$277K 0.01% 695
2020
Q1 		$2.81M Buy
+68,271
New +$3.79M 0.01% 668
2019
Q3 		– Sell
-117,586
Closed -$2.65M – 1365
2019
Q2 		$2.65M Sell
117,586
-8,278
-7% -$194K 0.01% 800
2019
Q1 		$2.92M Hold
125,864
– – 0.01% 779
2018
Q4 		$2.64M Hold
125,864
– – 0.01% 767
2018
Q3 		$4.87M Buy
125,864
+43,668
+53% +$1.61M 0.02% 684
2018
Q2 		$3.23M Buy
+82,196
New +$2.42M 0.01% 747

Other funds holding DCPH

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Axa's DCPH Position: Q2 2021 in Review

Axa sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2021, closing a stake of 6,400 shares — an estimated $287K sold.

Axa first reported a position in DCPH in Q2 2018 and held it in 10 quarters. The position peaked at $4.87M in Q3 2018. 147 funds tracked by Wall St. Rank hold DCPH as of Q2 2021.

  • Axa reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Axa sold 6,400 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2021, an estimated $287K.
  • Axa first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 10 quarters.
  • Axa's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $4.87M in Q3 2018.
  • 147 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on Axa's 13F filing for Q2 2021, filed 13 Aug 2021.